(Q43615492)

25 November 2017

title

Poor wound healing after pial synangiosis in 2 children with moyamoya vasculopathy associated with neurofibromatosis type 1. (English)

1 reference

25 November 2017

1 reference

1

Meredith R Golomb

1 reference

25 November 2017

Jodi L Smith

2

1 reference

25 November 2017

publication date

18 October 2013

1 reference

Journal of Child Neurology

25 November 2017

published in

1 reference

25 November 2017

volume

29

1 reference

25 November 2017

issue

10

1 reference

25 November 2017

page(s)

NP101-4

1 reference

Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073813506611

The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073813506611

Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073813506611

Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073813506611

Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073813506611

Cerebrovasculopathy in NF1 associated with ocular and scalp defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073813506611

Is Pulmonary Arterial Hypertension in Neurofibromatosis Type 1 Secondary to a Plexogenic Arteriopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073813506611

21 January 2018

Identifiers

DOI

10.1177/0883073813506611

1 reference

25 November 2017

1 reference